EVP, Research & Investments of Royalty Pharma Plc (NASDAQ:RPRX), Reddoch James F., sells 359 shares worth $15,193
According to Royalty Pharma Plc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 07:51 AM, company EVP, Research & Investments, Reddoch James F. disclosed selling 359 shares at a cost of $42.32. At the time of this transaction (Apr 12), this trade was worth $15,193 in total. As of Apr 12, Reddoch James F. now owns 255,714 shares in total worth about $10,798,802.219999999.
For the last few recent trades made by Royalty Pharma Plc (NASDAQ:RPRX) EVP, Research & Investments, Reddoch James F., we have the following information:
- SEC Form 4 filing: Mar 22: Sold 43,927 shares at the rate of $46.32 per share. Total worth of this trade was $2,034,519. Total number of shares owned as of Mar 22 were 256,073
- SEC Form 4 filing: Mar 02: Sold 100,000 shares at the rate of $46.92 per share. Total worth of this trade was $4,692,158. Total number of shares owned as of Mar 02 were 300,000
Posted by
George Daniels
on Wednesday April 14 2021, 12:11 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
